C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 5/06 (2006.01) A61K 38/05 (2006.01) A61K 38/12 (2006.01) A61P 31/14 (2006.01) C07K 5/062 (2006.01) C07K 5/065 (2006.01) C07K 5/08 (2006.01) C07K 5/12 (2006.01) C12N 9/50 (2006.01)
Patent
CA 2667165
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use treating or preventing HCV infections.
L'invention concerne des composés macrocycliques de formule (I) qui sont utiles en tant qu'inhibiteurs de la protéase NS3 (HCV) du virus de l'hépatite C, leur synthèse et leur utilisation dans le traitement ou la prévention d'infections HCV.
Di Francesco Maria Emilia
Liverton Nigel J.
Pompei Marco
Summa Vincenzo
Vacca Joseph P.
Gowling Lafleur Henderson Llp
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.p.a.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
LandOfFree
Hcv ns3 protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hcv ns3 protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv ns3 protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1409529